Intrinsic Value of S&P & Nasdaq Contact Us

Healthcare Realty Trust Incorporated HR NYSE

NYSE • Real Estate • REIT - Healthcare Facilities • US • USD

SharesGrow Score
36/100
1/7 Pass
SharesGrow Intrinsic Value
$14.40
-19.3%
Analyst Price Target
$19.67
+10.3%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Healthcare Realty Trust Incorporated (HR) has a negative trailing P/E of -25.1, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 594.7 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -3.99%, forward earnings yield 0.17%.

Criteria proven by this page:

  • VALUE (83/100, Pass) — analyst target implies upside (+10.3%).
  • Forward P/E 594.7 — analysts expect a return to profitability with estimated EPS of $0.03 for FY2029.
  • Trailing Earnings Yield -3.99% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 0.17% as earnings recover.
  • Analyst consensus target $19.67 (+10.3% upside) — modest upside expected.

Overall SharesGrow Score: 36/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score
36/100
SG Score
View full scorecard →
VALUE
83/100
Price-to-Earnings & upside
Proven by this page
~
FUTURE
40/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
MOAT
24/100
→ Income
~
GROWTH
48/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — HR

Valuation Multiples
P/E (TTM)-25.1
Forward P/E594.7
PEG RatioN/A
Forward PEGN/A
P/B Ratio1.34
P/S Ratio5.21
EV/EBITDA19.7
Per Share Data
EPS (TTM)$-0.70
Forward EPS (Est.)$0.03
Book Value / Share$13.36
Revenue / Share$3.37
FCF / Share$0.36
Yields & Fair Value
Earnings Yield-3.99%
Forward Earnings Yield0.17%
Dividend Yield5.84%
SharesGrow IV$14.40 (-19.3%)
Analyst Target$19.67 (+10.3%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 82.9 2.70 2.51 9.00 3.18%
2017 91.0 30.94 3.25 9.49 2.45%
2018 27.5 0.14 3.41 8.43 2.56%
2019 227.7 -2.66 3.61 9.90 3.73%
2020 122.7 2.04 3.31 8.78 4.27%
2021 67.7 0.77 2.07 8.44 3.89%
2022 118.9 -1.78 0.64 5.21 28.94%
2023 -23.5 0.04 0.96 4.86 7.23%
2024 -9.5 -0.07 1.18 4.89 7.39%
2025 -24.1 0.40 1.28 5.02 6.53%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $0.78 $411.96M $85.57M 20.8%
2017 $0.18 $424.5M $23.09M 5.4%
2018 $0.57 $450.39M $69.77M 15.5%
2019 $-0.08 $470.3M $-16.98M -3.6%
2020 $0.09 $499.63M $19.19M 3.8%
2021 $0.10 $534.82M $14.32M 2.7%
2022 $-0.42 $932.64M $-106M -11.4%
2023 $-0.74 $1.34B $-278.26M -20.7%
2024 $-1.81 $1.25B $-654.49M -52.4%
2025 $-0.71 $1.18B $-246.07M -20.8%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-0.09 $-0.09 – $-0.09 $1.13B $1.09B – $1.14B 2
2027 $-0.06 $-0.06 – $-0.06 $1.16B $1.16B – $1.17B 2
2028 $-0.03 $-0.04 – $-0.02 $1.18B $1.17B – $1.19B 2
2029 $0.03 $0.03 – $0.03 $1.14B $1.1B – $1.16B 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message